Uniphar (UPR) Competitors GBX 334.54 -0.46 (-0.14%) As of 11:58 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock UPR vs. UDG, BTG, ABC, HCM, INDV, GNS, ONT, CLIN, EMIS, and VECShould you be buying Uniphar stock or one of its competitors? The main competitors of Uniphar include UDG Healthcare (UDG), BTG (BTG), Abcam (ABC), HUTCHMED (HCM), Indivior (INDV), Genus (GNS), Oxford Nanopore Technologies (ONT), Clinigen Group (CLIN), EMIS Group (EMIS), and Vectura Group (VEC). These companies are all part of the "medical" sector. Uniphar vs. Its Competitors UDG Healthcare BTG Abcam HUTCHMED Indivior Genus Oxford Nanopore Technologies Clinigen Group EMIS Group Vectura Group UDG Healthcare (LON:UDG) and Uniphar (LON:UPR) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Is UDG or UPR a better dividend stock? UDG Healthcare pays an annual dividend of GBX 0.17 per share. Uniphar pays an annual dividend of GBX 0.02 per share and has a dividend yield of 0.0%. UDG Healthcare pays out 0.7% of its earnings in the form of a dividend. Uniphar pays out 7.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Do analysts rate UDG or UPR? Uniphar has a consensus target price of GBX 427.50, indicating a potential upside of 27.79%. Given Uniphar's stronger consensus rating and higher possible upside, analysts clearly believe Uniphar is more favorable than UDG Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UDG Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Uniphar 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media refer more to UDG or UPR? In the previous week, UDG Healthcare's average media sentiment score of 0.00 equaled Uniphar'saverage media sentiment score. Company Overall Sentiment UDG Healthcare Neutral Uniphar Neutral Which has better valuation and earnings, UDG or UPR? Uniphar has higher revenue and earnings than UDG Healthcare. UDG Healthcare is trading at a lower price-to-earnings ratio than Uniphar, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUDG Healthcare£1.25B0.00N/A£25.40N/AUniphar£2.89B0.30£51.04M£0.251,365.48 Is UDG or UPR more profitable? Uniphar has a net margin of 1.68% compared to UDG Healthcare's net margin of 0.00%. Uniphar's return on equity of 13.18% beat UDG Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets UDG HealthcareN/A N/A N/A Uniphar 1.68%13.18%3.76% Do insiders & institutionals have more ownership in UDG or UPR? 33.4% of Uniphar shares are owned by institutional investors. 7.7% of Uniphar shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryUniphar beats UDG Healthcare on 11 of the 13 factors compared between the two stocks. Get Uniphar News Delivered to You Automatically Sign up to receive the latest news and ratings for UPR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPR vs. The Competition Export to ExcelMetricUnipharMedical Distribution IndustryMedical SectorLON ExchangeMarket Cap£868.38M£868.38M£6.14B£2.61BDividend Yield0.49%1.27%5.66%5.28%P/E Ratio1,365.48109.2085.844,440.52Price / Sales0.3030.07626.36100,568.44Price / Cash9.979.9738.3227.90Price / Book2.622.6213.068.88Net Income£51.04M£51.04M£3.30B£5.89B7 Day Performance-1.97%-0.66%4.81%0.81%1 Month Performance-4.96%-0.49%9.99%5.86%1 Year Performance57.43%2.82%85.28%154.98% Uniphar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPRUnipharN/AGBX 334.54-0.1%GBX 427.50+27.8%+57.4%£868.38M£2.89B1,365.483,000UDGUDG HealthcareN/AN/AN/AN/A£2.72B£1.25B42.489,000BTGBTGN/AN/AN/AN/A£3.26B£914.10M29.474,690ABCAbcamN/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap UpHigh Trading VolumeHCMHUTCHMEDN/AGBX 231flatN/A-23.5%£1.98B£602.20M435.851,760News CoverageGap UpINDVIndivior2.0934 of 5 starsGBX 1,238+1.6%GBX 1,800+45.4%+65.3%£1.93B£1.40B-1,026.481,000Positive NewsGap UpHigh Trading VolumeGNSGenus1.7243 of 5 starsGBX 2,479.80+4.6%GBX 2,900+16.9%+23.3%£1.63B£672.80M-39,996.81480Gap DownONTOxford Nanopore Technologies1.7642 of 5 starsGBX 157.20+3.2%GBX 245+55.9%-1.1%£1.51B£204.69M-1,062.161,281News CoverageGap UpCLINClinigen GroupN/AN/AN/AN/A£1.23B£565.60M64.691,000EMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560VECVectura GroupN/AN/AN/AN/A£1.01B£190.60M8.209,200 Related Companies and Tools Related Companies UDG Alternatives BTG Alternatives ABC Alternatives HCM Alternatives INDV Alternatives GNS Alternatives ONT Alternatives CLIN Alternatives EMIS Alternatives VEC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:UPR) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Uniphar plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Uniphar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
